Consolidated Statements of Cash Flows	12 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)
Operating activities:
Net income (loss)	$ 317,705,000	$ 76,475,000	$ (85,778,000)
(Income) loss from discontinued operations	(347,532,000)	(6,145,000)	305,703,000
(Loss) income from continuing operations	(29,827,000)	70,330,000	219,925,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation expense	22,611,000	12,824,000	13,878,000
Amortization and adjustments to operating lease assets	44,748,000	50,651,000	52,781,000
Depreciation	44,574,000	33,888,000	32,278,000
Amortization of intangible assets	97,274,000	0	0
Amortization and write-off of debt discount and issuance costs	42,654,000	2,657,000	1,566,000
Reclassification adjustment from other comprehensive income	0	(126,000)	0
Provision for bad debts	27,141,000	11,023,000	14,431,000
Deferred income taxes	(544,000)	62,000	(5,423,000)
Loss on disposals, accelerated depreciation, and adjustments to property and equipment	3,501,000	1,912,000	4,564,000
Gain on extinguishment of debt	(2,072,000)	0	0
Realized and unrealized gain on investments	0	(2,638,000)	(18,000)
Realized gain on sale of assets	0	0	(4,779,000)
Gain on derivative	0	0	(110,723,000)
Changes in assets and liabilities:
Accounts receivable	(29,881,000)	15,443,000	(11,392,000)
Prepaid expenses and other current assets	569,000	(17,198,000)	(18,741,000)
Accounts payable	(15,724,000)	5,666,000	(9,421,000)
Accrued payroll and benefits	(13,268,000)	12,552,000	257,000
Accrued liabilities	(16,305,000)	29,312,000	1,265,000
Deferred revenue	65,075,000	5,312,000	(1,725,000)
Operating lease liabilities	(49,147,000)	(48,588,000)	(52,780,000)
Other assets and liabilities	(27,554,000)	(14,322,000)	(16,298,000)
Net cash provided by operating activities-continuing operations	163,825,000	168,760,000	109,645,000
Net cash (used in) provided by operating activities-discontinued operations	(153,401,000)	23,439,000	(1,953,000)
Net cash provided by operating activities	10,424,000	192,199,000	107,692,000
Investing activities:
Capital expenditures	(31,054,000)	(39,881,000)	(39,605,000)
Proceeds from sales of marketable securities	0	2,721,000	2,829,000
Purchases of marketable securities	0	(10,745,000)	(3,015,000)
Proceeds from sale of assets	0	0	6,421,000
Cash received on settlement of derivative	0	0	110,723,000
Cash received on purchase price adjustment	0	0	92,000
Payment for purchase of business, net of cash and restricted cash acquired	(1,488,054,000)	0	0
Cash received on DeVry University loan	10,000,000	0	0
Net cash (used in) provided by investing activities-continuing operations	(1,509,108,000)	(47,905,000)	77,445,000
Net cash used in investing activities-discontinued operations	(3,287,000)	(8,783,000)	(8,440,000)
Proceeds from sale of business, net of cash transferred	960,768,000	0	313,518,000
Net cash (used in) provided by investing activities	(551,627,000)	(56,688,000)	382,523,000
Financing activities:
Proceeds from exercise of stock options	8,879,000	1,457,000	3,761,000
Employee taxes paid on withholding shares	(2,834,000)	(4,206,000)	(5,485,000)
Proceeds from stock issued under Colleague Stock Purchase Plan	535,000	262,000	17,000
Repurchases of common stock for treasury	(120,000,000)	(100,000,000)	(136,889,000)
Payment for purchase of equity forward contract	(30,000,000)	0	0
Proceeds from long-term debt	850,000,000	800,000,000	225,000,000
Repayments of long-term debt	(1,079,713,000)	(3,000,000)	(338,000,000)
Payment of debt discount and issuance costs	(49,553,000)	(18,047,000)	0
Proceeds from down payment on seller loan	0	0	5,200,000
Payment for purchase of redeemable noncontrolling interest of subsidiary	(1,790,000)	0	(6,247,000)
Net cash (used in) provided by financing activities-continuing operations	(424,476,000)	676,466,000	(252,643,000)
Net cash used in financing activities-discontinued operations	0	0	(3,466,000)
Net cash (used in) provided by financing activities	(424,476,000)	676,466,000	(256,109,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	534,000	(33,468,000)
Net (decrease) increase in cash, cash equivalents and restricted cash	(965,679,000)	812,511,000	200,638,000
Cash, cash equivalents and restricted cash at beginning of period	1,313,616,000	501,105,000	300,467,000
Cash, cash equivalents and restricted cash at end of period	347,937,000	1,313,616,000	501,105,000
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	0	18,236,000	17,726,000
Cash, cash equivalents and restricted cash of continuing operations at end of period	347,937,000	1,295,380,000	483,379,000
Cash paid during the year for:
Interest	107,093,000	14,429,000	20,156,000
Income taxes, net	94,355,000	26,431,000	12,442,000
Decrease in redemption value of redeemable noncontrolling interest put option	$ 0	$ (628,000)	$ 0